The federal contract award is for the delivery of XGEVA 120 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,017.44 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 27, 2024, with a completion date of November 29, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 2/26/25, 9:45 AM